Anti-psychotics - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

Anti-psychotics

Description:

Anti-psychotics Mainstay of pharmacological treatment for schizophrenia and related disorders Diminish positive symptoms such as hallucinations, delusions, thought ... – PowerPoint PPT presentation

Number of Views:181
Avg rating:3.0/5.0
Slides: 41
Provided by: hop0
Category:

less

Transcript and Presenter's Notes

Title: Anti-psychotics


1
Anti-psychotics
  • Mainstay of pharmacological treatment for
    schizophrenia and related disorders
  • Diminish positive symptoms such as
    hallucinations, delusions, thought disorder
  • Some impact on negative symptoms such as lack of
    motivation, blunted affect, cognitive impairment
  • Important as a part of relapse prevention

2
Anti-psychotics
  • Antagonise dopamine receptors, resulting in
    anti-psychotic effects
  • Indications-schizophrenia, acute mania, psychotic
    depression,
  • Conventional and atypical
  • Both of equivalent efficacy when taken at
    recommended dosages
  • Atypicals have lower incidence of EPSE

3
Dopamine Theory
  • The dopamine hypothesis of psychosis
    overactivity of dopamine neurons in the
    mesolimbic pathway of the brain may mediate the
    positive symptoms of psychosis
  • Mesolimbic pathway responsible for pleasure,
    effects of drugs and alcohol and hallucinations
    and delusions

4
Blockade Of D2 Receptors?
5
Dopamine Receptors
  • Five subtypes D2 most important in terms of
    psychosis
  • Blockade of mesolimbic receptors leads to reduced
    psychotic symptoms
  • Blockade of the mesocortical pathway leads to
    increased negative symptoms

6
Dopamine Receptors
  • Dopamine and acetylcholine have a reciprocal
    relationship-
  • Blockade of dopamine receptors increases the
    activity of acetylcholine
  • Over activity of acetylcholine causes EPSE
  • Blockade of dopamine causes movement disorders in
    the nigostriatal pathway
  • Long tem blockade causes upregulation and leads
    to Tardive Dyskinesia

7
Conventional or typical Antipsychotics
  • Have four actions blockade of
  • Dopamine 2
  • Muscarinic/cholinergc
  • Alpha adrenergic
  • Histamine

8
Serotonin and Dopamine Interactions
9
The Dopamine Receptor Antagonist Hypothesis of
Antipsychotic drug Action
  • Blockade of post synaptic dopamine receptors in
    the mesolimbic pathway is thought to mediate the
    efficacy of the drug and its ability to diminish
    positive symptoms

10
Receptor Affinity
  • Low Affinity (loosely bound)
  • - Quetiapine, Olanzapine, Amisulpride,
    Clozapine
  • High Affinity (tightly bound)
  • - Chlorpromazine, Haloperidol, Flupenthixol,
    Fluphenazine
  • Tightly bound drugs lead to increased sensitivity
    to dopamine blockade so more likely to cause EPSE

11
Atypical Antipsychotics
  • Pharmacologic Properties
  • 5HT2A and D2 antagonism (as opposed to
    conventional drugs which are D2 without 5HT2A
    antagonism)
  • Atypicals blockade of D2 and 5HT2A

12
Dopamine and Serotonin Receptors
  • Dopamine and serotonin have a reciprocal
    relationship
  • Serotonin opposes the release of dopamine in the
    nigrostriatal and tuberofundibular pathways

13
Dopamine and Serotonin Receptors
  • Action of atypicals firstly binds to the D2
    receptor
  • Secondly, binds to the 5HT2A receptor
  • The second action reverses the first reverses
    the blockade of D2
  • Blocking 5HT2A disinhibits the dopamine neuron
    causing dopamine to pour out

14
Dopamine and Serotonin Receptors
  • The dopamine and serotonin then compete with the
    drug for the D2 receptor
  • Increased dopamine in the mesocortical pathway
  • Reduction in movement disorders/EPSE for atypical
    antipsychotics

15
Atypicals
  • In reality not simple serotonin-dopamine
    antagonists
  • Most complex pharmacological properties
  • Act on multiple serotonin and dopamine receptors,
    histamine, alpha adrenergic cholinergic

16
Atypicals versus conventional
  • All equal efficacy (except Clozapine)
  • Consideration for
  • Merits of high versus low affinity drugs
  • Cerebral selectivity of the drugs
  • Adverse effect profile
  • Dose necessary to achieve optimal D2 blockade
  • Patient tolerability, preference, response

17
Anti-psychotics
  • Conventional eg chlorpromazine, haloperidol,
    stelazine, depots such as flupenthixol,
    zuclopenthixol, fluphenazine
  • Atypical eg olanzapine, risperidone,
    quetiapine, amisulpride, clozapine, risperdal
    consta intramuscular injection, aripiprazole,
    paliperidone, ziprasidone
  • Also have effects on acetylcholine,
    histamine,serotonin receptors varying adverse
    effects

18
Atypical antipsychotics
  • The newer antipsychotics
  • Effectively treat psychotic symptoms
  • Lower incidence of extra pyramidal side effects
    than conventional agents
  • Have effects on dopamine, serotonin, histamine
    and muscarinic receptors

19
Atypical antipsychotics
  • Current atypicals in use in Australia are
  • Amisulpride
  • Aripiprazole
  • Quetiapine
  • Olanzapine
  • Risperidone
  • Clozapine
  • Ziprasidone
  • Paliperidone

20
Therapeutic effects on symptoms
  • Agitation, sleep and appetite often respond in
    the first 1-2 weeks
  • Personal hygiene and basic interpersonal
    socialisation may take 2-3 weeks and psychotic
    symptoms can gradually decrease over 2-6 weeks
  • An effective trial should be at least 6-8 weeks
    at doses that are within the prescribed range

21
How long should antipsychotics be taken for?
  • At least 6 months after an acute episode reduces
    relapse rates
  • If the person experiences another episode they
    may need antipsychotic medication for 2-5 years
    before ceasing use
  • For those with multiple episodes, they may need
    medication for much of their life

22
Adverse Effects
  • Sedation
  • Postural hypotension
  • Anticholinergic effects dry mouth, blurred
    vision, constipation, urinary hesitancy
  • Weight gain-clozapine, olanzapine
  • Metabolic effects-increased serum lipids,
    impaired glucose tolerance-clozapine, olanzapine,
    quetiapine

23
Adverse Effects
  • Hyperprolactinaemia-leads to
    galactorrhoea, amenorrhoea, decreased libido
  • Sexual dysfunction
  • QTc prolongation-leads to cardiac arrhythmias
  • EPSE-extrapyramidal side effects
  • Acute dystonias -laryngeal spasm, oculogyric
    crises
  • Akathisia-severe sense of agitation, inner
    restlessness in the limbs, especially the legs

24
(No Transcript)
25
Adverse Effects
  • Akathesia a severe sense of psychomotor
    agitation
  • Parkinsonism -poverty of movement, tremor,
    rigidity, drooling, hypersalivation
  • Tardive dyskinesia-involuntary hyperkinetic
    movements, affects the mouth, lips, tongue, jaws
    with smacking, tongue writhing, sucking,chewing
    and tic like movements,limbs and trunk can be
    affected

26
Adverse Effects
  • Irreversible in some patients
  • Neuroleptic malignant syndrome-rare but
    potentially fatal high temp, muscle rigidity,
    altered consciousness, raised creatinine kinase
    cease medication
  • Can happen at anytime during treatment
  • 30 patients will develop syndrome again on
    rechallenge

27
Depot Anti-psychotics
  • Used when concerns around compliance
  • Conventional-zuclopenthixol(useful for
    agitated,aggressive,disturbed behaviour)
    flupenthixol (may have mood elevating effects)
    fluphenazine -EPSE common
  • Typical-Risperdal Consta onset of action 3
    weeks, need oral Risperidone to supplement until
    peak plasma reached

28
Comparative Information for Anti-Psychotics
Chlorpromazine, Pericyazine Most sedating, most potent anticholinergic effects, least likely to cause EPSE, most likely to cause orthostatic hypotension. Low potency antipsychotics
Trifluperazine, Fluphenazine Moderately sedating, intermediate propensity to cause EPSE, some potential to cause orthostatic hypotension
Haloperidol, Droperidol, Thiothixene, Pimozide Least sedating, almost no anticholinergic effects, most likely to cause EPSE, least likely to cause orthostatic hypotension, sometimes referred to as high potency antipsychotics
29
Atypical antipsychotics
Amisulpride Less potential for weight gain and sedation
Aripiprazole May cause insomnia, less potential for hyperprolactinaemia
Clozapine Effective treatment-resistant patients but has serious side-effects (blood dyscrasias, seizures, cardiomyopathy, myocarditis, orthostatic hypotension, sedation, weight gain).
30
Atypical antipsychotics
Olanzapine Related to Clozapine may cause sedation, weight gain, peripheral oedema increased risk of stroke and related mortality in elderly dementia patients
Quetiapine Sedating and vasoactive, less potential for hyperprolactinaemia
Risperidone, Paliperidone Orthostatic hypotension and hyperprolactinaemia, may be a problem increased risk of stroke and related mortality in elderly dementia patients
Ziprasidone Less potential for weight gain
31
Drug Interactions
  • Cytochrome P450 isoenzymes are significant in
    psychotropic drug interactions
  • Inducers or inhibitors of this pathway may
    produce clinically important drug interactions
  • May lead to increase or decrease of medications
    due to interactions

32
Cytochrome P450
  • Examples
  • Fluvoxamine inhibits olanzapine and clozapine
    metabolism
  • Smoking induces Olanzapine metabolism
  • SSRIs inhibit most antipsychotics and therefore
    increase serum concentrations
  • Phenytoin reduces serum concentration of
    Quetiapine
  • Others grapefruit juice, Antibiotics,

33
Clozapine
  • Used when previously unresponsive to other
    antipsychotics
  • Serious adverse effect profile
  • Strict guidelines relating to commencement and
    monitoring
  • Significant risk of agranulocytosis
  • Trial at least 2 different standard
    antipsychotics at an adequate dose and for an
    adequate duration prior to commencing Clozapine

34
Use of antipsychotics with older persons
  • Various disorders treated with antipsychotics in
    the elderly psychosis, bipolar affective
    disorder, delirium dementia
  • Use extreme caution because of side effect
    profile
  • Start low go slow (Malone et al 2007)
    titrate over longer periods of time to reach the
    required dose
  • Avoid polypharmacy wherever possible

35
Pregnancy lactation
  • Avoid antipsychotics if possible
  • Use the lowest effective dose
  • Neonatal adverse effects observed include
    generalised hypertonicity and dystonic reactions

36
Pregnancy lactation
  • The safety of atypical agents is yet to be
    established but preliminary reports there to be
    no deleterious effects to the foetus
  • Isolated cases of congenital abnormalities with
    the use of Clozapine

37
Pregnancy Lactation
  • No increased risk has emerged with the use of
    Olanzapine
  • The conventional agents are generally preferred
  • Supervised dose reduction and cessation 7-10 days
    prior to delivery should be considered

38
What other treatments are available?
  • Remember that antidepressant medication is only
    part of the
  • treatment for antenatal depression and anxiety.
    Also consider
  • Psychological therapies
  • Exclude organic illness as a cause of mental
    health symptoms
  • Address any alcohol and/or illicit substance
    abuse
  • Assess the social situation
  • General lifestyle measures adequate rest/sleep,
    balanced diet, exercise
  • The decision to treat should be made on an
    individual case basis
  •  

39
Conclusion
  • Conventional and atypical antipsychotics are used
    as the foundation for pharmacological management
    of schizophrenia and related psychosis
  • All have equal efficacy, exception Clozapine
  • Atypicals generally better tolerated have less
    EPSE
  • Atypicals first line treatment
  • Start lowest effective possible dose titrate
    upwards
  • Ongoing monitoring management of adverse
    effects
  • Caution numerous drug interaction potential for
    neuroleptic malignant syndrome

40
Resources
  • Therapeutic Guidelines Psychotropic Version 5
  • www.tg.com.au 9329 1566
  • Australian Medicines Handbook
  • www.amh.net.au 08 8303 6977
  • MIMS online
  • http//www.ppmis.org.au Perinatal Psychotropic
    Medicine Information Service
Write a Comment
User Comments (0)
About PowerShow.com